Skip to Content

SEC Filings

Filing date	Form	Description	View
Nov 04, 2021	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-21-054518.pdf 0001564590-21-054518.rtf 0001564590-21-054518.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 05, 2022	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-22-018284.pdf 0001564590-22-018284.rtf 0001564590-22-018284.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Aug 04, 2022	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-22-028022.pdf 0001564590-22-028022.rtf 0001564590-22-028022.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Nov 03, 2022	10-Q	Quarterly report which provides a continuing view of a company's financial position	0000950170-22-021933.pdf 0000950170-22-021933.rtf 0000950170-22-021933.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT View HTML
May 04, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	0000950170-23-017932.pdf 0000950170-23-017932.rtf 0000950170-23-017932.xls EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT View HTML
Aug 03, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	0000950170-23-038082.pdf 0000950170-23-038082.rtf 0000950170-23-038082.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Nov 02, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	0000950170-23-058273.pdf 0000950170-23-058273.rtf 0000950170-23-058273.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT View HTML
Feb 07, 2017	PRER14A	Proxy soliciting materials. Revised preliminary material	0001193125-17-032485.pdf 0001193125-17-032485.rtf 0001193125-17-032485.xls View HTML
Apr 26, 2018	PRER14A	Proxy soliciting materials. Revised preliminary material	0001564590-18-009329.pdf 0001564590-18-009329.rtf 0001564590-18-009329.xls View HTML
Aug 16, 2019	PRER14A	Proxy soliciting materials. Revised preliminary material	0001193125-19-223588.pdf 0001193125-19-223588.rtf 0001193125-19-223588.xls View HTML

Data provided by Kaleidoscope.

Back to top

Merrimack Pharmaceuticals, Inc.
One Broadway, 14th floor
Cambridge, MA 02142
617-720-8606
info@merrimack.com

© 2024 Merrimack Pharmaceuticals.